The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Bulgakov S.A.

State budgetary educational institution of higher professional education «N.I. Pirogov Russian National Research Medical University», Russian Ministry of Health, Moscow, Russia

Peptide therapeutics in pancreatology

Authors:

Bulgakov S.A.

More about the authors

Journal: Russian Journal of Evidence-Based Gastroenterology. 2018;7(4): 30‑34

DOI: 10.17116/dokgastro2018704130

Read: 12546 times

Download PDF (RU)
Contact the author
Table of contents

PEPTIDE THERAPEUTICS IN PANCREATOLOGY
PEPTIDE THERAPEUTICS IN PANCREATOLOGY

To cite this article:

Bulgakov SA. Peptide therapeutics in pancreatology. Russian Journal of Evidence-Based Gastroenterology. 2018;7(4):30‑34. (In Russ.)
https://doi.org/10.17116/dokgastro2018704130

Подписка 2026 Доказательная гастроэнтерология (Russian Journal of Evidence-Based Gastroenterology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Imme­diate resu­lts of medi­cine Slavinorm treatment in patients with athe­rosclerotic arte­ries diseases of the lower extremities. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):102-108
The author’s Time­less protocol: biostimulating peptides and pico­second alexandrite laser as an inno­vative approach to cellular reju­venation. Plastic Surgery and Aesthetic Medi­cine. 2025;(1):80-89
Cystic-solid transformation of the pancreas and kidneys due to von Hippel-Lindau disease. Piro­gov Russian Journal of Surgery. 2025;(10):118-125
Abstract:

Pancreatic disease management using peptide drugs is reviewed in the article. Somatostatin, octreotide and synthetic analogue of leucine — enkephalin dalargin are under precise attention. Despite various studies of therapeutic effect of these drugs in acute pancreatitis and pancreatic necrosis, their effectiveness is still unclear due to absent works performed according to criteria of evidence-based medicine. It is reported about new medicine «Daloctin P» that is a combination of octreotide and dalargin.

Keywords:

pancreas
diseases
drugs
peptides

Authors:

Bulgakov S.A.

State budgetary educational institution of higher professional education «N.I. Pirogov Russian National Research Medical University», Russian Ministry of Health, Moscow, Russia

Close metadata

References:

  1. Heinrich S, Schafer V, Rousson V, Clavien P.A. Evidence — based treatment of acute pancreatitis: a look at established paradigms. Ann Surg. 2006;243:154-168. https://doi.org/10.1097/01.sla.0000197334.58374.70
  2. Gel’fand BR, Burnevich SZ, Grojzik KL. Preparaty somatostatina v neotlozhnoj pankreatologii: sostojanie i perspektiva. Vestnik intensivnoj terapii. 1998;3:19-24. (In Russ.)
  3. Smagin VG, Vinogradov VA, Bulgakov SA. Ligandy opiatnyh receptorov. M.: Nauka, 1983;270. (In Russ.)
  4. Limberg K, Kommerell B. Treatment of acute pancreatitis with somatostatin. New Eng J Med. 1980;79:284.
  5. Choi TK, Mok F, Zhan W, Fan ST, Wong J. Somatostatin in the treatment of acute pancreatitis: a prospective randomized controlled trial. Gut. 1989;30:223-227. https://doi.org/10.1136/gut.30.2.223
  6. Usadel KH, Uberla KK, Leuschner U. Treatment of acute pancreatitis with somatostatin: results of the multicenter double-blind trial (APTS). Dig Dis Sci.1985;30 A 992.
  7. McKay C, Baxter J, Imrie C. A randomized, controlled trial of octreotide in the management of patients with acute pancreatitis. Int J Pancreatol. 1997;21:13-19.
  8. Uhl W, Buchler MW, Malfertheiner P, Beger HG, Adler G, Gaus W. A randomized, double blind, multicenter trial of octreotide in moderate to severe acute pancreatitis. Gut. 1999;45:97-104. https://doi.org/10.1136/gut.45.1.97
  9. Uhl W, Warshaw A, Imrie C. IAP Guidelines for the surgical management of acute pancreatitis. Pancreatology. 2002;2:565-573. https://doi.org/10.1159/000067684
  10. Vinogradov VA, Smagin VG, Titov MI. Sinteticheskie peptidy kak lekarstvennye veshhestva. Nejropeptidy v jeksperimental. i klinich. praktike. M. 1986;3-7. (In Russ.)
  11. Bulgakov SA. Agonisty opiatnyh receptorov v gastrojenterologicheskoj praktike. Dokazatel’naja gastrojenterologiya. 2015;4(1):14-18. (In Russ.) https://doi.org/10.17116/dokgastro201541-214-18
  12. Il’inskij OB, Spevak SE, Shekhter AB. Novyj peptidnyj aktivator reparativnoj regeneracii tkanej. Farmakol.i toksikol. 1987;4:64-66. (In Russ.)
  13. Bulgakov SA. Dalargin v gastrojenterologii. M. 2008. (In Russ.)
  14. Georgadze AK, Permjakov NK, Penin VA, et al. Jeffektivnost’ dalargina v kompleksnom lechenii bol’nyh s razlichnymi formami ostrogo pankreatita. Nejropeptidy: ih rol’ v fiziologii i patologii. Tomsk. 1985;167-168. (In Russ.)
  15. Vasil’ev RKh, Stanulis AI, Osadchaya LV, Panphilov SA, Kaminskij NV. Lazery i nejropeptidy v lechenii sochetannyh zabolevanij zheludka, dvenadcatiperstnoj kishki i podzheludochnoj zhelezy. Aktual’nye voprosy lazernoj meditsiny. M. 1991;88-89. (In Russ.)
  16. Grigus YaI, Mikhajlova OD, Bulychyov VF, Gorbunov AYu. Otsenka jeffektivnosti dalargina v lechenii postgastrorezekcionnogo pankreatita. Prakticheskaja meditsina. 2012;3:78-82. (In Russ.)
  17. Voskanjan SJe, Korsakov IN, Najdyonov EV. Profilaktika ostrogo posleoperatsionnogo pankreatita v khirurgii raka podzheludochnoj zhelezy. Gepatol. 2013;2:95. (In Russ.)
  18. Onopriev VI, Voskanyan SJe, Korsakov IN. Prophilaktika ostrogo posleoperatsionnogo pankreatita posle radikal’noj duodenoplastiki. Kubanskij nauch med vestnik. 2006;7-8:107-115. (In Russ.)
  19. Krylov NN, Egorov AV, Latiphova LV, Vychuzhanin DV. Kliniko-jekonomicheskie aspekty medikamentoznoj profilaktiki ostrogo posleoperacionnogo pankreatita. Vesti hirurg gastrojenterol. 2011;1:10. (In Russ.)
  20. Bulgakov SA. Dalargin v pankreatologii. Ros zhurnal gastrojenterologii, gepatologii, koloproktologii. 2009;5:67. (In Russ.)
  21. Minushkin ON, Maslovskij LV. Jetiologicheskie aspekty terapii hronicheskih pankreatitov. Consilium medicum. 2005;6:444-447. (In Russ.)
  22. Korobov NV. Otechestvennye innovacionnye lekarstvennye sredstva: mesto dalargina v lechenii ostrogo pankreatita. Vedomosti nauchnogo tsentra jekspertizy sredstv meditsinskogo primeneniya. 2007;4:93-98. (In Russ.)
  23. Bespalova ZhD, Ovchinikov MV, Chertorizhskij EA, Yasnetsov VV, Ivanov YuV. Patent RF na izobretenie №RU 2341282/24.0.2007. Farmacevticheskaja kompozicija, obladajushhaja pankreatotropnoj aktivnost’ju, i sposob poluchenija farmacevticheskoj kompozicii. (In Russ.)
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.